Therefore, several markers of tolerance, such as PDL1, TIM3, and LAG3, were evaluated in tumor cells and at the TME by single and double IHC in 47 DLBCL cases with available material for analysis, in order to confirm gene expression findings (Fig. 3a–e). Here, LAG3 is linked to diffuse large B-cell lymphoma.